{"id":15972,"date":"2014-03-12T10:45:57","date_gmt":"2014-03-12T15:45:57","guid":{"rendered":"http:\/\/cmeded.wpengine.com\/?page_id=15972"},"modified":"2023-09-21T21:44:05","modified_gmt":"2023-09-22T02:44:05","slug":"risk-factors","status":"publish","type":"page","link":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/","title":{"rendered":"Factores de riesgo"},"content":{"rendered":"<h4 class=\"section-title\">Factores de riesgo<\/h4>\n<p class=\"section-content\">Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el octavo linfoma m\u00e1s com\u00fan tanto en hombres como en mujeres. Aunque no se conocen las causas exactas de la mayor\u00eda de los linfomas, los m\u00e9dicos reconocen ciertos \"factores de riesgo\" para el desarrollo de este c\u00e1ncer. Un factor de riesgo es una caracter\u00edstica, comportamiento o condici\u00f3n que aumenta la posibilidad de desarrollar una enfermedad. Estos son algunos factores que se sabe que aumentan el riesgo de desarrollar linfoma no Hodgkin:<\/p>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\">\n<div style='width: 100%; height: 100%; display: flex; flex-wrap: wrap; justify-content: center; align-items: center'>\n<img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/11\/weakness.jpg\" alt=\"Edad\" style=\"height:125px;\"><br \/>\n<img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/10\/OldMan127x175.png\" alt=\"Edad\" style=\"height:125px;\">\n<\/div>\n<\/div>\n<\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Edad<\/h5>\n<p class=\"section-content\">El linfoma no Hodgkin aparece con m\u00e1s frecuencia en personas mayores de 60 a\u00f1os de edad, aunque algunas formas aparecen en personas m\u00e1s j\u00f3venes.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\">\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/04\/OldMan150.jpg\" class=\"aligncenter\" alt=\"G\u00e9nero\" style=\"height:117px;\"><\/p>\n<\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">G\u00e9nero<\/h5>\n<p class=\"section-content\">El riesgo general que corren los hombres de padecer el linfoma no Hodgkin es mayor en comparaci\u00f3n con las mujeres, aunque algunos tipos de la enfermedad predominan en las mujeres.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\"><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/05\/three-white-men-150.jpg\" class=\"aligncenter\" alt=\"Raza\" style=\"height:115px\"><\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Raza<\/h5>\n<p class=\"section-content\">El riesgo que corren las personas de raza blanca de padecer el linfoma no Hodgkin es mayor en comparaci\u00f3n con el de las personas afroamericanas y asi\u00e1ticas americanas.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\"><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/03\/Virus125.jpg\" class=\"aligncenter\" alt=\"Virus y bacterias\" style=\"height:100px\"><\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Virus y bacterias<\/h5>\n<p class=\"section-content\">La infecci\u00f3n por el virus de Epstein-Barr (VEB), la bacteria de Helicobacter pylori y el virus de la hepatitis C (VHC) puede aumentar el riesgo de que aparezca el linfoma no Hodgkin.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\"><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/03\/HIVAIDS.png\" class=\"aligncenter\" alt=\"Inmunodeficiencia\" style=\"height:100px\"><\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Inmunodeficiencia<\/h5>\n<p class=\"section-content\">Si el sistema inmunitario de una persona est\u00e1 debilitado a ra\u00edz del VIH, un trasplante de \u00f3rgano o determinadas caracter\u00edsticas gen\u00e9ticas heredadas, puede aumentar el riesgo de que esta tenga un linfoma no Hodgkin.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\"><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/05\/Hands150.jpg\" class=\"aligncenter\" alt=\"Enfermedades autoinmunitarias\" style=\"height:100px\"><\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Enfermedades autoinmunitarias<\/h5>\n<p class=\"section-content\">Las enfermedades autoinmunitarias, como el lupus y la artritis reumatoide, pueden aumentar el riesgo de contraer el linfoma no Hodgkin.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\"><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/03\/Diet.jpg\" class=\"aligncenter\" alt=\"Alimentaci\u00f3n y obesidad\" style=\"height:100px\"><\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Alimentaci\u00f3n y obesidad<\/h5>\n<p class=\"section-content\">Tener sobrepeso (obeso) o tener una alimentaci\u00f3n con contenido alto de grasas y carnes rojas puede aumentar el riesgo de contraer linfoma no Hodgkin.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n<div class=\"divider\" id=\"\">\n\t\n\t<\/div>\n<div class=\"risk-factor\">\n<div class=\"risk-pic\">\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2013\/02\/Exposure150.jpg\" alt=\"Exposiciones debido a la ocupaci\u00f3n o el medioambiente\" class=\"aligncenter\" style=\"height:135px;\"\/><\/p>\n<\/div>\n<div class=\"risk-text\">\n<h5 class=\"section-title\">Exposiciones debido a la ocupaci\u00f3n o el medioambiente<\/h5>\n<p class=\"section-content\">La exposici\u00f3n a toxinas cancer\u00edgenas, como pesticidas e insecticidas, puede aumentar el riesgo de contraer el linfoma no Hodgkin. Determinados medicamentos tambi\u00e9n pueden aumentar el riesgo de aparici\u00f3n de los linfomas.<\/p>\n<p class=\"section-content\">Ciertos medicamentos, en particular los que inhiben el sistema inmunol\u00f3gico, tambi\u00e9n pueden aumentar el riesgo de desarrollar linfomas.<\/p>\n<\/div>\n<div class=\"clearboth\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el octavo linfoma m\u00e1s com\u00fan tanto en hombres como en mujeres. Aunque no se conocen las causas exactas de la mayor\u00eda de los linfomas, los m\u00e9dicos reconocen ciertos \u00abfactores de [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":15969,"menu_order":2,"comment_status":"closed","ping_status":"open","template":"template-tumor.php","meta":{"footnotes":""},"tags":[10],"class_list":["post-15972","page","type-page","status-publish","hentry","tag-members-only"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo<\/title>\n<meta name=\"description\" content=\"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo\" \/>\n<meta property=\"og:description\" content=\"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/\" \/>\n<meta property=\"og:site_name\" content=\"CMedEd\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-22T02:44:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/\",\"url\":\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/\",\"name\":\"CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo\",\"isPartOf\":{\"@id\":\"https:\/\/cmeded.com\/es\/#website\"},\"datePublished\":\"2014-03-12T15:45:57+00:00\",\"dateModified\":\"2023-09-22T02:44:05+00:00\",\"description\":\"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el\",\"breadcrumb\":{\"@id\":\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cmeded.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Linfoma\",\"item\":\"https:\/\/cmeded.com\/es\/lymphoma\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Informaci\u00f3n para comprender el linfoma no Hodgkin\",\"item\":\"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Factores de riesgo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cmeded.com\/es\/#website\",\"url\":\"https:\/\/cmeded.com\/es\/\",\"name\":\"CMedEd\",\"description\":\"Recurso principal de informaci\u00f3n sobre el c\u00e1ncer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cmeded.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo","description":"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/","og_locale":"es_ES","og_type":"article","og_title":"CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo","og_description":"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el","og_url":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/","og_site_name":"CMedEd","article_modified_time":"2023-09-22T02:44:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/","url":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/","name":"CMedEd | Informaci\u00f3n para comprender el linfoma no Hodgkin | Factores de riesgo","isPartOf":{"@id":"https:\/\/cmeded.com\/es\/#website"},"datePublished":"2014-03-12T15:45:57+00:00","dateModified":"2023-09-22T02:44:05+00:00","description":"Factores de riesgo Aproximadamente una de cada 45 a 50 personas desarrollar\u00e1 linfoma en alg\u00fan momento de su vida. El linfoma no Hodgkin es actualmente el","breadcrumb":{"@id":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/risk-factors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cmeded.com\/es\/"},{"@type":"ListItem","position":2,"name":"Linfoma","item":"https:\/\/cmeded.com\/es\/lymphoma\/"},{"@type":"ListItem","position":3,"name":"Informaci\u00f3n para comprender el linfoma no Hodgkin","item":"https:\/\/cmeded.com\/es\/lymphoma\/understanding-non-hodgkin-lymphoma\/"},{"@type":"ListItem","position":4,"name":"Factores de riesgo"}]},{"@type":"WebSite","@id":"https:\/\/cmeded.com\/es\/#website","url":"https:\/\/cmeded.com\/es\/","name":"CMedEd","description":"Recurso principal de informaci\u00f3n sobre el c\u00e1ncer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cmeded.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/pages\/15972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/comments?post=15972"}],"version-history":[{"count":0,"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/pages\/15972\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/pages\/15969"}],"wp:attachment":[{"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/media?parent=15972"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cmeded.com\/es\/wp-json\/wp\/v2\/tags?post=15972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}